Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Probiatop in the Treatment of Digestive Symptoms
NCT05603403Phase 4Completed
- Sponsor
- Azidus Laboratories Limited
- Start
- Oct 2022
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial (2 arms), sponsored by Azidus Laboratories Limited. Primary endpoint: Clinical Outcome Measure: Efficacy at 42 days. Started Oct 2022; status: completed.
Beyond the preview
Go deeper on NCT05603403.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05603403.